Dedicated UPLC/MS System Solutions Taking on Increased Challenges in Laboratories for Therapeutic Drug Monitoring, Disease Management, Endocrinology, and Toxicology
The MassTrak Immunosuppressants XE RUO Kit is for clinical research laboratories seeking an alternative to immunoassay kits for quantitative measurement of immunosuppressant drug levels. Each kit includes reagents, controls, and calibrators, a tuning mixture for the mass spectrometer, and an analytical column for performing up to 500 determinations /kit. Used with Waters ACQUITY TQD System, the MassTrak Immunosuppressants XE RUO Kit achieves high specificity in measuring the target analyte in the presence of drug metabolites and addresses some of the analytical weaknesses of immunoassay immunosuppressant drug measurement.
The new MassTrak Immunosuppressants XE RUO Kit is one of several innovative applications for LC/MS/MS that Waters is spotlighting at AACC 2009.
Vitamin D Analysis
Vitamin D deficiency has been associated with an increased risk of
osteoporosis, heart disease, diabetes and other maladies. In the
The test method features a solid-phase extraction sample preparation step that minimizes solvent usage, enhances automation, eliminates the need for solvent evaporation and sample reconstitution. Further information on the new method is included in a new product handout available online from Waters (Part No. 720003044EN).
Amino Acid Analysis
Over the past 50 years, amino acid analysis has come to be recognized as a cornerstone in the nutritional and metabolic research laboratory. At AACC, Waters is featuring its MassTrak Amino Acid Analysis Solution, a comprehensive approach to the full profile analysis of physiological amino acids in urine and plasma in a research environment. This solution incorporates a Waters ACQUITY UPLC system with pre-packaged, fully tested reagents and consumables, pre-defined analytical, processing and reporting methods and dedicated support, training and installation services from Waters for the fastest possible start-up and continued productivity in the clinical research laboratory.
LC/MS/MS is now widely used in confirmation analysis in clinical toxicology. The sensitivity, speed, selectivity and simple sample pre-treatment requirements have led to LC/MS/MS methods being adopted as the preferred choice for many important applications. At AACC, Waters will exhibit its ACQUITY UPLC system and tandem mass spectrometry products for this fast-growing application area.
In connection with this area of clinical analysis, Waters has posted two
video testimonials featuring CEO Dr.
For Further Information
Waters is sponsoring an industry workshop on
LC/MS/MS for the
LC/MS/MS is now finding a role in the routine clinical laboratory, with many laboratories using the technique for a variety of testing including toxicology, therapeutic drug monitoring and endocrinology. Improvements in assay performance, usability, reliability and software capabilities are key drivers for its adoption. Waters introduction of innovative system platforms, standardized methods and reagents to support these solution requirements are enabling more laboratories to adopt this powerful analytical approach.
In 2007, Waters received clearance from the
Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.
With revenue of
Waters, MassTrak, ACQUITY, ACQUITY UPLC, UltraPerformance LC, and UPLC are
Web Site: http://www.waters.com